Cargando…
CD19 LYMPHOCYTE PROLIFERATION INDUCED BY Bifidobacterium animalis subsp. lactis IN C57BL/6 MICE EXPERIMENTALLY INFECTED WITH Toxoplasma gondii
Toxoplasmosis is frequently acquired through the oral route by the ingestion of cysts or oocysts of Toxoplasma gondii. Once ingested, the parasites penetrate the intestinal epithelial cells and rapidly disseminate to all organs in the host. During T. gondii infection, the intestinal microbiota plays...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto de Medicina Tropical
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826079/ https://www.ncbi.nlm.nih.gov/pubmed/27074320 http://dx.doi.org/10.1590/S1678-9946201658026 |
_version_ | 1782426285384925184 |
---|---|
author | RIBEIRO, Claudia de Mello ZORGI, Nahiara Esteves MEIRELES, Luciana Regina GARCIA, João Luis de ANDRADE, Heitor Franco |
author_facet | RIBEIRO, Claudia de Mello ZORGI, Nahiara Esteves MEIRELES, Luciana Regina GARCIA, João Luis de ANDRADE, Heitor Franco |
author_sort | RIBEIRO, Claudia de Mello |
collection | PubMed |
description | Toxoplasmosis is frequently acquired through the oral route by the ingestion of cysts or oocysts of Toxoplasma gondii. Once ingested, the parasites penetrate the intestinal epithelial cells and rapidly disseminate to all organs in the host. During T. gondii infection, the intestinal microbiota plays an important role in stimulating a protective immune response against the parasite. In this sense the use of probiotics is worthy of note since they are live microorganisms that have beneficial effects on the host through stimulation of the immune response that can be important in the control of T. gondii proliferation and dissemination in the host. In the present study, the action of the probiotic Bifidobacterium animalis subsp. lactis was investigated in C57BL/6 mice infected with oocysts of ME49 strain of T. gondii. The probiotic had an immunomodulatory action, inducing CD19 lymphocyte proliferation and consequently increasing anti-T. gondii antibody level.Bifidobacterium animalis subsp. lactisprovided protection in supplemented mice, compared to the control group. In addition, supplemented animals had milder inflammatory process in the small intestine, indicating that the probiotic protects the intestinal mucosa during infection with T. gondii. It was concluded that the probioticB. animalis subsp. lactis induces humoral immune response capable of providing protection against T. gondii infection. |
format | Online Article Text |
id | pubmed-4826079 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Instituto de Medicina Tropical |
record_format | MEDLINE/PubMed |
spelling | pubmed-48260792016-04-21 CD19 LYMPHOCYTE PROLIFERATION INDUCED BY Bifidobacterium animalis subsp. lactis IN C57BL/6 MICE EXPERIMENTALLY INFECTED WITH Toxoplasma gondii RIBEIRO, Claudia de Mello ZORGI, Nahiara Esteves MEIRELES, Luciana Regina GARCIA, João Luis de ANDRADE, Heitor Franco Rev Inst Med Trop Sao Paulo Original Article Toxoplasmosis is frequently acquired through the oral route by the ingestion of cysts or oocysts of Toxoplasma gondii. Once ingested, the parasites penetrate the intestinal epithelial cells and rapidly disseminate to all organs in the host. During T. gondii infection, the intestinal microbiota plays an important role in stimulating a protective immune response against the parasite. In this sense the use of probiotics is worthy of note since they are live microorganisms that have beneficial effects on the host through stimulation of the immune response that can be important in the control of T. gondii proliferation and dissemination in the host. In the present study, the action of the probiotic Bifidobacterium animalis subsp. lactis was investigated in C57BL/6 mice infected with oocysts of ME49 strain of T. gondii. The probiotic had an immunomodulatory action, inducing CD19 lymphocyte proliferation and consequently increasing anti-T. gondii antibody level.Bifidobacterium animalis subsp. lactisprovided protection in supplemented mice, compared to the control group. In addition, supplemented animals had milder inflammatory process in the small intestine, indicating that the probiotic protects the intestinal mucosa during infection with T. gondii. It was concluded that the probioticB. animalis subsp. lactis induces humoral immune response capable of providing protection against T. gondii infection. Instituto de Medicina Tropical 2016-04-08 /pmc/articles/PMC4826079/ /pubmed/27074320 http://dx.doi.org/10.1590/S1678-9946201658026 Text en http://creativecommons.org/licenses/by-nc/4.0 This is an open-access article distributed under the terms of the Creative Commons Attribution License |
spellingShingle | Original Article RIBEIRO, Claudia de Mello ZORGI, Nahiara Esteves MEIRELES, Luciana Regina GARCIA, João Luis de ANDRADE, Heitor Franco CD19 LYMPHOCYTE PROLIFERATION INDUCED BY Bifidobacterium animalis subsp. lactis IN C57BL/6 MICE EXPERIMENTALLY INFECTED WITH Toxoplasma gondii |
title | CD19 LYMPHOCYTE PROLIFERATION INDUCED BY Bifidobacterium
animalis subsp. lactis IN C57BL/6 MICE EXPERIMENTALLY
INFECTED WITH Toxoplasma gondii
|
title_full | CD19 LYMPHOCYTE PROLIFERATION INDUCED BY Bifidobacterium
animalis subsp. lactis IN C57BL/6 MICE EXPERIMENTALLY
INFECTED WITH Toxoplasma gondii
|
title_fullStr | CD19 LYMPHOCYTE PROLIFERATION INDUCED BY Bifidobacterium
animalis subsp. lactis IN C57BL/6 MICE EXPERIMENTALLY
INFECTED WITH Toxoplasma gondii
|
title_full_unstemmed | CD19 LYMPHOCYTE PROLIFERATION INDUCED BY Bifidobacterium
animalis subsp. lactis IN C57BL/6 MICE EXPERIMENTALLY
INFECTED WITH Toxoplasma gondii
|
title_short | CD19 LYMPHOCYTE PROLIFERATION INDUCED BY Bifidobacterium
animalis subsp. lactis IN C57BL/6 MICE EXPERIMENTALLY
INFECTED WITH Toxoplasma gondii
|
title_sort | cd19 lymphocyte proliferation induced by bifidobacterium
animalis subsp. lactis in c57bl/6 mice experimentally
infected with toxoplasma gondii |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826079/ https://www.ncbi.nlm.nih.gov/pubmed/27074320 http://dx.doi.org/10.1590/S1678-9946201658026 |
work_keys_str_mv | AT ribeiroclaudiademello cd19lymphocyteproliferationinducedbybifidobacteriumanimalissubsplactisinc57bl6miceexperimentallyinfectedwithtoxoplasmagondii AT zorginahiaraesteves cd19lymphocyteproliferationinducedbybifidobacteriumanimalissubsplactisinc57bl6miceexperimentallyinfectedwithtoxoplasmagondii AT meireleslucianaregina cd19lymphocyteproliferationinducedbybifidobacteriumanimalissubsplactisinc57bl6miceexperimentallyinfectedwithtoxoplasmagondii AT garciajoaoluis cd19lymphocyteproliferationinducedbybifidobacteriumanimalissubsplactisinc57bl6miceexperimentallyinfectedwithtoxoplasmagondii AT deandradeheitorfranco cd19lymphocyteproliferationinducedbybifidobacteriumanimalissubsplactisinc57bl6miceexperimentallyinfectedwithtoxoplasmagondii |